Sonnet BioTherapeutics Holdings, Inc.
Sonnet BioTherapeutics Holdings, Inc. (SONN) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 86 transactions totaling $248.5K, demonstrating a bullish sentiment with $248.5K in net insider flow. The most recent transaction on Dec 2, 2025 involved a transaction of 14,116 shares valued at $0.
SONN Insider Activity Summary
Who Is Buying SONN Stock?
No significant insider buying has been recorded for SONN in the recent period.
Who Is Selling SONN Stock?
No significant insider selling has been recorded for SONN in the recent period.
Is Sonnet BioTherapeutics Holdings, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SONN is bullish with an Insider Alignment Score of 100/100 and a net flow of $248.5K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SONN Frequently Asked Questions
Understanding SONN Insider Activity
Insider trading at Sonnet BioTherapeutics Holdings, Inc. (SONN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading SONN stock, having executed 86 transactions in the past 90 days. The most active insider is Pankaj Mohan (Executive), who has made 14 transactions totaling $176.6K.
Related Tools
Track Sonnet BioTherapeutics Holdings, Inc. Insider Activity
Get notified when executives and directors at SONN file new Form 4 transactions